Stryker receives FDA clearance for 3D-printed expandable interbody device — 4 things to know

Alan Condon -   Print  |

The FDA granted Stryker FDA 510(k) clearance for its Sahara Lateral 3D expandable interbody system.


Four things to know:

1. The expandable implant features K2M's Lamellar 3D Titanium Technology, which uses a 3D printing process and high-energy laser beam to develop porous, titanium surfaces.

2. The Sahara Lateral device has expansion capabilities designed for surgeons to achieve up to 30 degrees of sagittal spinal correction in skeletally mature patients.

3. The implant can be adjusted intraoperatively from a lateral approach or in a staged posterior approach following osteotomy.

4. Sahara Lateral will be exhibited at the Society for Minimally Invasive Spine Surgery Annual Forum in Las Vegas from Oct. 31 to Nov. 2.

More articles on orthopedic devices:
Orthofix reports $40.5M loss & more: 7 device company notes
SeaSpine posts $39.9M Q3 revenue
Stryker Q3 net sales hit $3.6B; spine sales up 35%

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers